KEI Industries Employee Stock Options

KEI Industries Earnings Call Transcript: Key Takeaways

KEI delivered robust 38% revenue growth led by domestic demand, yet margins saw slight contraction.

Call

Guides 25% growth

KEI Industries Other Announcement

CRISIL assigned KEI Industries an ESG rating of 65 (Strong) and Core ESG rating of 73 for FY 2025-26. This is a periodic ESG rating disclosure with no financial or operational implication.

KEI Industries Investor Presentation: Key Takeaways

KEI reports strong Q2 FY27 with revenue growing 38.5% YoY to ₹3,777 Cr, driven by robust domestic Wires & Cables demand. PAT rose 29% YoY to ₹262 Cr.

KEI Industries Q2 FY27 Results: Net Profit ₹262.4 Cr, Up 28.9% YoY

KEI Industries Ltd reported revenue from operations of ₹3,776 Cr (+38.5% YoY) and net profit of ₹262.4 Cr (+28.9% YoY) for Q2 FY27.

Key figure

Net profit ₹262.4 Cr · +28.9% YoY

KEI Industries Other Announcement

KEI Industries reported an ESG rating of '71' (Excellent category) assigned by an external agency, noting it did not commission this independent report.

KEI Industries Board Meeting Date

KEI Industries has scheduled its Board meeting for 21 October 2026 to review Q1 and H1 FY27 results. The trading window remains closed until 23 October 2026.

RateGain Travel Technologies Employee Stock Options

RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.

Execution

Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting

Aye Finance Employee Stock Options

Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.

Aarti Pharmalabs Employee Stock Options

Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.

OnEMI Technology Solutions Employee Stock Options

OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.

Bliss GVS Pharma Employee Stock Options

Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.

Bandhan Bank Employee Stock Options

Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.